News Snapshot:
China approves Chinese anti-HIV drug Azwudine treating covid-19 in adults Follow the news, press follow, live news On July 25, the South China Morning Post reported that China’s National Administration of Medical Products said in an announcement on Monday. Grants conditional approval for the use of Azvudine, the anti-HIV drug produced by Genuine Biotech, a Chinese pharmaceutical company. to treat adults with COVID-19 Recommended news This is to expand the scope of use of Azwoodine. It was previously approved in July last year to treat people with HIV-1 (HIV-1), and Azvudine will be a Chinese-made oral antiviral drug. First to...
